Retevmo (selpercatinib) for the Treatment of RET-Driven Cancers

RetevmoTM (selpercatinib) is available as an oral capsule with dosage strengths of 40mg and 80mg. Credit: Eli Lilly and Company.



  • Retevmo
  • Retevmo
  • Retevmo